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Abstract 
Polypyrimidine tract binding (PTB) protein is an abundant and widely 
expressed RNA binding protein with four RNA Recognition Motif (RRM) 
domains. PTB is involved in numerous post-transcriptional steps in gene 
expression in both the nucleus and cytoplasm, but has been best-
characterized as a regulatory repressor of some alternative splicing events 
(ASEs), and as an activator of translation driven by internal ribosome entry 
segments (IRESs).  We have used a variety of approaches to characterize the 
activities of PTB and its molecular interactions with RNA substrates and 
protein partners. Using splice-sensitive microarrays we found that PTB acts 
not only as a splicing repressor but also as an activator, and that these two 
activities are determined by the location at which PTB binds relative to target 
exons. We have identified minimal splicing repressor and activator domains, 
and have determined high resolution structures of the second RRM domain of 
PTB binding to peptide motifs from the co-repressor protein Raver1. Using 
single-molecule techniques we have determined the stoichiometry of PTB 
binding to a regulated splicing substrate in whole nuclear extracts.  Finally, we 
have used tethered hydroxyl radical probing to determine the locations on 
viral IRESs at which each of the four RRM domains bind.  We are now 
combining tethered probing with single molecule analyses to gain a detailed 
understanding of how PTB interacts with pre-mRNA substrates to effect either 
repression or activation of splicing.  
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Polypyrimidine tract binding protein (PTB) is an abundant RNA binding protein 
of the hnRNP family, originally identified by its binding to the polypyrimidine 
tract at the 3´ splice site of mammalian introns [1, 2]. Structurally, PTB 
consists of four RNA Recognition Motif (RRM) domains [3], with three 
interdomain linkers and an N-terminal leader sequence containing nuclear 
localization and export signals (Fig. 1A). Early speculation that PTB was an 
essential pre-mRNA splicing factor was rapidly dispelled, and it was 
subsequently recognized as a repressive regulator of alternative splicing [4]. 
In vitro selection experiments showed that optimal binding substrates for PTB 
consisted of motifs such as UCUUC embedded within more extended 
pyrimidine-rich contexts [5, 6]. Such motifs were found in splicing silencer 
elements associated with many PTB repressed exons (Fig. 1B). PTB was also 
found to be involved in regulating numerous other post-transcriptional 
processes in both the nucleus and cytoplasm, including 3´-end processing, 
mRNA stability, internal ribosome entry segment (IRES) driven translation and 
mRNA localization [7]. Of these processes, most experimental attention has 
focused on the roles of PTB as a repressor of splicing and activator of IRES-
mediated translation initiation. Here we discuss a range of approaches that 
we have deployed recently to analyze the roles of PTB and its interactions 
with RNA targets and protein partners.  
 
PTB splicing maps 
PTB has been investigated as a splicing repressor in numerous model 
systems, allowing a number of general principles about its mode of action to 
be discerned. A number of models have been suggested to explain, in whole 
or part, PTB’s repressive activity including: direct binding competition with 
U2AF65 at the polypyrimidine tract; propagative binding between high affinity 
sites; looping of RNA between high affinity sites; inhibition of productive 
splicing complex assembly across introns or exons [8, 9]. In contrast, until 
recently only a couple of reports had suggested that PTB might be able to 
activate some splicing events. However, new insights have been facilitated by 
splice-sensitive microarrays, which allow quantitative profiling of large 
numbers of alternative splicing events (ASEs) in parallel, and by UV cross-
linking immunoprecipitation (CLIP) followed by high-throughput sequencing, 
which allows a transcriptome-wide view of RNA-protein interactions [10]. 
Array analysis of cells in which PTB was knocked down identified large 
numbers of PTB-regulated ASEs [11, 12]. Although most of these ASEs were 
conventional targets of PTB-repression, there was a substantial minority of 
PTB-activated events. By combining functional PTB-target events from our 
array experiments with a transcriptome-wide PTB CLIP data-set [13] it was 
possible to decipher differences in the characteristics of PTB-repressed and 
PTB-activated cassette exons [12] (Fig. 2). In agreement with previous work, 
PTB-repressed exons were associated with PTB binding upstream of or within 
the regulated exon. However, in contrast to some well-studied PTB-repressed 
exons, including -tropomyosin (Tpm1) exon 3 [14, 15] and SRC N1 exon 
[16], we found no general tendency for PTB binding downstream of repressed 
exons. In contrast, the newly characterized PTB-activated exons were clearly 
associated with PTB binding on the downstream side of the exon [12]. These 
exons had weaker 5 splice sites than PTB-repressed or control alternative 
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exons, suggesting that PTB-binding in the downstream intron might be able to 
compensate for a weak 5 splice site. However, by insertion of a PTB-binding 
site in the upstream intron, the exon became repressed by PTB, and the 
downstream site was converted from a PTB binding enhancer to a silencer 
[12]. PTB joins a growing list of splicing regulatory proteins showing a similar 
position-dependent activity [10]. This poses a series of questions about how 
the same protein can have opposite regulatory outcomes depending upon the 
location and number of binding sites, and also how several diverse proteins 
are able to activate splicing when bound downstream of a weak 5´ splice site 
[10]. The protein TIA1 can activate splicing by direct contact with U1C protein, 
thereby assisting U1 snRNP recruitment [17]. Perhaps other activators 
contact different components of U1 snRNP to assist its recruitment? Indeed 
PTB RRMs 1 and 2 have been shown to contact U1 snRNA, albeit in the 
context of repressing the SRC N1 exon [18].  
 
Functional domains of PTB 
Understanding the molecular function of biological macromolecules is 
invariably assisted by detailed structural information. Although full-length PTB 
has eluded high resolution structural determination, the structures of all four 
PTB RRMs have been determined by NMR, in both free form as well as 
bound to a hexameric CUCUCU RNA ligand [19-22]. This has revealed the 
basis of specificity of RNA recognition by each RRM (Fig. 1A), as well as 
interesting features of RRM organization. Notably, while the linkers between 
RRMs 1, 2 and 3 are flexible [23], RRMs 3 and 4 form a stable di-domain with 
back to back packing of the two RRMs involving the short linker [20, 22]. This 
di-domain structure necessitates a loop of at least 15 nt between the two 
pyrimidine tracts recognized by RRMs 3 and 4; targeted mutations to disrupt 
the didomain packing impair PTBs regulatory activity on SRC splicing [24]. 
Thus, it appears that the RRMs of PTB may serve not just to recognise 
specific sequence motifs, but also to bring about structural rearrangements of 
the RNA. Nevertheless, other lines of evidence suggest that PTB has 
additional effector functions that are distinct from RNA binding.  
We previously exploited “artificial tethering” to map a minimal repressor 
domain of PTB [25]. The PTB binding silencer downstream of Tpm1 exon 3 
was replaced by a binding site for bacteriophage MS2 coat protein. 
Repression of the exon by PTB was thereby abrogated, but could be restored 
by expressing a fusion of PTB-MS2 coat protein. Consistent with the MS2 
protein now providing RNA-binding function, deletion analysis showed that 
three of PTB’s four RRMs were dispensable. A minimal repressor domain 
consisted of just RRM2 and the following inter-RRM linker [25]. We had also 
found that the protein Raver1, initially identified by yeast 2-hybrid assays as a 
PTB interactor [26], was able to strongly promote skipping of Tpm1 exon 3 
[27]. We identified four short peptide motifs in Raver1, of the form 
[S/G][I/L]LGxxP, which could interact with PTB. The motifs were subsequently 
referred to as PTB RRM interacting (PRI) motifs [28]. NMR experiments 
showed that the high affinity PRI3 motif interacted with PTB RRM2 on its 
dorsal surface, and that RRM2 was able to form a ternary complex with RNA 
bound to the -sheet surface and the PRI3 peptide bound in a shallow 
hydrophobic groove on the dorsal surface [29]. Much more detailed 
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information about the Raver1-PTB interaction has now been obtained by X-
ray crystallography of PTB RRM2 linked via a flexible linker to Raver1 PRI 
motifs [30]. Fortuitously, the two fusion proteins that crystallized (diffracting to 
<1.6 Å) contained PRI3 and 4, which are the highest and lowest affinity PRI 
motifs from Raver1. The structural data therefore provided a wealth of 
information about the recognition of PRIs by PTB RRM2. In particular, the 
side-chain of PTB Tyr 247 is a focal point for apolar contacts from a pair of 
hydrophobic side-chains in the PRI motifs (L3 and P6 of PRI3, L3 and L5 of 
PRI4). The importance of Tyr 247 was confirmed by a Y247Q mutation, which 
caused a loss of Raver1 binding in vitro and a 30% reduction in the activity of 
the MS2 minimal PTB repressor domain. Perhaps more surprising was that 
mutation of the RNA binding surface of RRM2 had an even larger effect in the 
MS2 assay (60-90% loss of activity), even though the MS2 protein brings the 
fusion protein to the location of the original PTB binding site [30]. This raises 
the question of the RNA site that must be bound by PTB RRM2. One 
possibility, suggested by in vitro experiments in HeLa extracts, is that the 
tethered PTB interacts with the pyrimidine tract upstream of exon 3, thereby 
forming a protein-bridged RNA loop (M Coelho & CWJS, unpublished 
observations). Alternatively, it is possible that the tethered RRM2 interacts 
with U1 snRNA, as demonstrated for the SRC N1 exon [18].  
 We have also used the MS2 approach with PTB activated exons, 
initially focusing on an exon in the KTN1 gene [12]. Both full-length PTB as 
well as RRM2 and the following linker were able to activate inclusion of the 
KTN1 exon. In contrast, RRMs 3 and 4 fused to MS2 had the opposite effect, 
slightly increasing exon skipping. Thus, at least for the Tpm1 and KTN1 
exons, the minimal repressor and activator domains comprise RRM2 and the 
following linker. However, the KTN1 exon is not an ideal experimental model 
since the amplitude of response to PTB knockdown or MS2-PTB recruitment 
is quite modest. We are therefore repeating these analyses with other exons 
that are more responsive to PTB, with a view to carrying out a more detailed 
comparison of minimal repressor and activator domains. We will combine this 
approach with analyses of protein (and RNA) binding targets of the minimal 
effectors, as described recently for Rbfox proteins [31]. Using in vitro pull-
down assays with recombinant RRM2 wild type and Y247Q mutant proteins 
we have already found that a number of other nuclear proteins interact with 
the surface of PTB RRM2 recognised by PRI motifs (M. Coelho & CWJS, 
unpublished observations). These proteins are candidate splicing co-
regulators and/or targets of PTB’s repressor domain.  
 
Counting proteins in complexes 
PTB typically interacts with more than one pyrimidine tract in the region of 
exons that it represses. To fully understand how PTB functions, it is important 
to know how many PTB molecules bind to target RNAs. Conventional 
biochemical assays, such as electrophoretic mobility shift or filter-binding, 
have shown that splicing substrates typically bind more than one PTB 
molecule [14-16, 32]. However, these analyses have used pure recombinant 
PTB, which could easily lead to overestimates of the true number of 
molecules bound in vivo, where non-specific binding will be suppressed by the 
numerous other proteins that coat the RNA. To circumvent this problem, 
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Cherny et al [14] devised a single molecule approach, using total internal 
reflection fluorescence (TIRF) microscopy to image the binding of GFP-
tagged PTB to substrate RNAs immobilized on a slide using Cy-5 labelled 
complementary oligonucleotides. The PTB-GFP was present in nuclear 
extracts from transiently transfected HeLa cells, and PTB-RNA interactions 
were observed by colocalization of Cy5 and GFP fluorescence. The number 
of bound PTBs was determined either by analysis of successive 
photobleaching steps or by modelling cumulative distributions of total photon 
counts. This approach was used to analyse binding of PTB to substrates 
containing Tpm1 exon 3, which is flanked by two long pyrimidine tracts that 
act as PTB-binding silencer elements (Fig. B, [5, 15]). The data indicated that 
5-6 PTB molecules bound around Tpm1 exon 3, thereby ruling out models for 
PTB repression involving propagative binding of PTB between the distantly 
separated high affinity binding tracts [8, 9]. Using the specificities of individual 
RRM binding to RNA (Fig. 1A, [20]), and assuming a short but flexible 
separation of sites bound by RRMs 1, 2 and 3, we were able to model how 3 
PTBs would bind to the upstream and 2 to the downstream pyrimidine tract. 
An important insight was that not only could both of the high affinity tracts 
accommodate 2 or 3 PTB molecules, in agreement with experimental 
observations, but that there were numerous ways in which this could be 
achieved, with multiple overlapping arrangements for the specific RRM-RNA 
contacts. We suggest that the potential for multiple binding configurations may 
be a hallmark of high affinity binding sites. Indeed, many  motifs enriched in 
the vicinity of PTB regulated exons (e.g. UCUCU)[12] have embedded 
overlapping motifs for individual PTB RRMs. Our model required that the 
RRM4 domains would contact the RNA outside of the P3 and DY PTB-binding 
pyrimidine tracts. An additional C-rich tract upstream of exon 3 is a candidate 
site (Fig. 1B), which is consistent with the observed specificity of RRM4 (Fig 
1A). In order to test this model, we need an experimental approach that can 
facilitate systematic determination of the sites contacted by individual RRMs. 
Such an approach has been developed to interrogate the interaction of PTB 
with viral IRESs.  
Mapping the sites of PTB RRM contacts with IRESs 
In contrast to the unpaired pyrimidine tracts that typically mediate splicing 
repression by PTB, IRESs are highly structured. PTB contacts short 
pyrimidine rich loops as well as sequences that are predicted to be at least 
partially base-paired  [7]. Despite the higher degree of structural order in 
IRES-PTB complexes, high resolution structures of full length PTB bound to 
IRES substrates have not been obtained. Kafasla and Jackson therefore 
adapted the tethered hydroxyl radical probing approach, originally used to 
map binding sites of ribosomal proteins on rRNAs [33]. A battery of PTB 
mutants were generated, each with a single cysteine residue inserted close to 
the RNA binding surface of one of the RRM domains [34]. Modification of 
cysteine with Fe(II)BABE allows the localized generation of short-lived 
reactive hydroxyl radicals, which can cleave the RNA backbone within a 
limited distance (~10-35 Å). Mapping the cleavage sites by reverse 
transcription primer extension reveals the region of the RNA contacted by 
individual RRMs. This approach was applied to the highly structured 
encephalomyocarditis virus (EMCV) and poliovirus (PV) IRESs [34, 35]. 
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Combined with non-denaturing mass-spectrometry, which revealed that two 
PTBs bind to the EMCV IRES, but only one to the poliovirus IRES, this 
allowed for the first time the positions of individual PTB RRMs to be mapped 
onto the distinct RNA structural domains of the two IRESs. The importance of 
individual RRM-RNA contacts was next tested by combining mutations 
designed to disrupt RNA binding by individual RRMs, with the single cysteine 
mutants to report on the RNA contacts by the mutated RRM and the 
remaining functional RRMs [36]. Inactivation of any individual RRM domain 
reduced affinity modestly but did not impair or reposition RNA contacts by the 
remaining RRMs. However, the effects upon IRES activity were variable. For 
EMCV, only mutation of RRM2 led to full loss of activity; mutation of RRM1, 3 
or 4 had moderate effects, but combined mutation of RRMs 3 and 4 
eliminated activity. In contrast, the PV IRES was inactivated by mutations of 
RRMs 1, 2 or 4, but tolerated mutation of RRM3 surprisingly well. RRMs 1 
and 2 mapped to the structured region of domain V of the PV IRES, adjacent 
to the site of eIF4G binding; in contrast, RRMs 3 and 4 contacted the single 
stranded regions flanking the base of domain V. This agrees with independent 
reports that RRMs 1 and 2 favour structured RNAs while RRMs 3 and 4 bind 
better to single stranded pyrimidine tracts [37]. Moreover, PTB and eIF4G 
were seen to reciprocally modulate each others’ position of binding, 
suggesting that PTB activation of the PV IRES involves optimizing the position 
of eIF4G for translation initiation just downstream of domain V [35].  
 
Going forward – tethered probing of splicing substrates 
The set of PTB single cysteine mutants for tethered hydroxyl radical probing, 
combined with the RRM mutations to selectively impair RNA binding by 
individual RRMs, can potentially be applied to various PTB substrate RNAs 
involved in other steps of gene expression, including PTB regulated ASEs. 
We initially attempted to use tethered hydroxyl radical probing to investigate 
the sites at which individual PTB RRMs contact the Tpm1 RNA. However, 
under a wide range of conditions it was difficult to detect specific signals (PK 
unpublished observations), despite the fact that we know that 5-6 PTB 
molecules bind to this substrate [14]. However, Tpm1 might be a particularly 
challenging substrate for this kind of analysis due to the large number of 
bound PTBs. It is likely that there are numerous different binding 
arrangements for the multiple RRMs interacting with the extended pyrimidine 
tracts, which would produce poor signal to noise ratio in the tethered probing 
assay. For this reason, we are applying tethered probing to FAS exon 6 [38], 
in which a single 16 nt exonic sequence (referred to as URE6) is the only 
known element required for PTB-induced exon skipping (Fig. 1B). Skipping of 
FAS exon 6 in HeLa nuclear extracts is promoted by the addition of 
recombinant PTB, thereby allowing monitoring of functional activity, as well as 
RRM-RNA contacts by the modified single-cysteine PTBs. Moreover, the 
single-molecule TIRF approach can be used to determine the stoichiometry of 
PTB-RNA interactions [14], which is necessary for interpretation of the 
probing data. As discussed at the RNA UK 2012 meeting, these combined 
approaches are now allowing us to build a picture of how the RRMs of PTB 
interact with the FAS RNA, both within URE6 and at previously unidentified 
locations, to promote exon skipping.  
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Figure legends 
Figure 1. Schematic representation of PTB and PTB-repressed exons. 
A) Domain organization of PTB. The four RNA Recognition Motif (RRM) 
domains are shown, with the specific RNA sequence motifs recognized by 
each RRM shown below [20], and the PRI peptide motif recognized by the 
dorsal surface of RRM2 shown above [28-30].  
B) Depiction of rat Tpm1 exon 3 and human FAS exon 6. These are well 
characterized PTB-repressed exons, as discussed in the text. Known PTB 
binding motifs (P3, DY, URE6) are indicated by black boxes, with the 
sequences shown above. Sequence motifs resembling the optimal selected 
PTB-binding motifs are shown bold and underlined. In addition, the sequence 
of an additional C-rich tract upstream of Tpm1 exon 3 is shown. The grey 
circles represent additional elements needed for repression of the exon [39], 
and which bind Mbnl proteins (C.G. & CWJS, unpublished observations). The 
black circle upstream of P3 is the branch point for exon 3.  
 
Figure 2. Schematic PTB splicing map as revealed by transcriptome wide 
analysis of PTB-regulated splicing events and binding targets [12]. Top: exons 
that are repressed by PTB are associated with PTB-binding on the upstream 
intronic flank and/or within the exon.  Bottom: exons that are activated by PTB 
are associated with PTB-binding in the immediate downstream intronic flank.  
 
Figure 3. Schematic representation of the interaction of PTB with picornaviral 
IRESs as mapped by tethered hydroxyl radical probing combined with mass 
spectrometric analysis [34, 35]. The four RRMs of PTB are depicted by oval 
lines of different shading as shown. Top: Two PTB molecules interact with the 
EMCV IRES. Bottom: One PTB molecule binds on the PV IRES. The dashed 
oval  line shows the proposed position of the central domain of eIF4G [40].  
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